Literature DB >> 31135000

Raman and single-crystal X-ray diffraction evidence of pressure-induced phase transitions in a perovskite-like framework of [(C3H7)4N] [Mn(N(CN)2)3].

Mirosław Mączka1, Ines E Collings, Fabio Furtado Leite, Waldeci Paraguassu.   

Abstract

We report complementary high-pressure Raman and single-crystal X-ray diffraction studies of a perovskite-like dicyanamide framework of [(C3H7)4N][Mn(N(CN)2)3] ([TPrA][Mn(dca)3]). Our studies show that the bulk modulus of the ambient pressure P4[combining macron]21c phase is B0 = 8.1(11) GPa, and the ab-plane compresses by 54.4(15) × 10-3 GPa-1 and the c-axis by 8.0(12) × 10-3 GPa-1, indicating the low stiffness of the framework and its highly anisotropic nature. [TPrA][Mn(dca)3] transforms near 0.4 GPa into the Pbcn phase. The driving forces for this symmetry change are partial ordering of the dicyanamide (dca) linkers, off-center shifts of TPrA+ cations and large changes in the columnar shifts of the MnN6 octahedra within the ab-plane. Upon further increase of pressure, [TPrA][Mn(dca)3] undergoes symmetry-lowering transitions into a monoclinic phase (space group P21/n) near 3 GPa and a triclinic phase near 5 GPa. The observed structural changes are, however, very subtle.

Entities:  

Year:  2019        PMID: 31135000     DOI: 10.1039/c9dt01648a

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  2 in total

1.  Vibrational Properties and DFT Calculations of Perovskite-Type Methylhydrazinium Manganese Hypophosphite.

Authors:  Aneta Ciupa-Litwa; Maciej Ptak; Edyta Kucharska; Jerzy Hanuza; Mirosław Mączka
Journal:  Molecules       Date:  2020-11-09       Impact factor: 4.411

2.  Novel hypophosphite hybrid perovskites of [CH3NH2NH2][Mn(H2POO)3] and [CH3NH2NH2][Mn(H2POO)2.83(HCOO)0.17] exhibiting antiferromagnetic order and red photoluminescence.

Authors:  Mirosław Mączka; Anna Gągor; Adam Pikul; Dagmara Stefańska
Journal:  RSC Adv       Date:  2020-05-19       Impact factor: 4.036

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.